Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Valion Bio, Inc. - Common stock (NQ:VBIO)

2.000 -0.140 (-6.54%)
Delayed Quote Updated: 10:11 AM EDT, Oct 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 18,242
Open 2.100
Bid (Size) 2.000 (500)
Ask (Size) 2.030 (100)
Prev. Close 2.140
Today's Range 2.000 - 2.140
52wk Range 2.050 - 32.50
Shares Outstanding 112,282,745
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Valion Bio (Nasdaq:VBIO): Oral Mucosal Entolimod Could Offer a New Needle-Free Deployment Path to Support Growing Need for Scalable Civilian Radiation Preparedness Should Nuclear Infrastructure Expand to Support Data Centers
Rising electricity demand from AI and data centers is driving plans to expand nuclear power capacity, possibly including on-site small modular reactors (SMRs)¹ Medical countermeasures need to scale... 
From Valion Bio, Inc.
Via ACCESS Newswire
News headline image
New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround Experience to the Advancement of Entolimod
Jensen, who as CEO led Nasdaq-listed biotech Allarity Therapeutics' refocusing around a single lead asset, cites Valion's rare combination of government funding, FDA designations, human safety data and... 
From Valion Bio, Inc.
Via ACCESS Newswire

Performance

52-Week Range 93.8% below 52-week high
2.000
2.0552W Low 32.5052W High
1 Week 19.7% below 1-week high
2.071W Low 2.491W High

Valion Bio, Inc. - Common stock (VBIO) traded between $2.05 and $32.50 over the past 52 weeks and last traded at $2.00, 93.8% below its 52-week high. Over the past week it ranged between $2.07 and $2.49.

Past 12 Months
-19.4%
-11.5%
-84.3%
-92.1%
-92.1%
-92.1%
1W -$0.48
1M -$0.26
3M -$10.70
6M -$23.25
YTD -$23.25
1Y -$23.25

VBIO was -92.1% over the past year, -92.1% over six months, -92.1% year to date, -19.4% in the last week.

12 Months vs Market
VBIO
-92.1%
DIA
+12.4%
SPY
+17.3%
QQQ
+23.9%
IWM
+13.8%

Over the past 12 months VBIO returned -92.1% versus DIA (Dow) +12.4%, SPY (S&P 500) +17.3%, QQQ (Nasdaq 100) +23.9% and IWM (Russell 2000) +13.8%.

Volume & Liquidity 0.01× 3-mo avg
Today 18,242 3-mo avg 1.5M
1W
171.6K
1M
3.3M
3M
1.5M
6M
818.9K
YTD
818.9K
1Y
818.9K

VBIO most recently traded 18,242 shares against a 3-month average daily volume of 1.5M.

More News

Read More
Wednesday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
Valion Bio and Shear Kershman Laboratories Successfully Formulate Oral Mucosal Entolimod; Valion Sees Potential for Multi-Fold Expansion of Long-Term Opportunity
From Valion Bio, Inc.
Via ACCESS Newswire
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions
From Valion Bio, Inc.
Via ACCESS Newswire
News headline image
Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
From Valion Bio, Inc.
Via ACCESS Newswire
News headline image
Valion Bio Announces Changes to Management and Board of Directors
From Valion Bio, Inc.
Via ACCESS Newswire
Top movers analysis one hour before the close of the markets on 2026-08-27: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
Valion Bio Announces Reverse Stock Split
From Valion Bio, Inc.
Via ACCESS Newswire
Which stocks are moving after the closing bell on Monday? ↗
Via Chartmill
Top movers in Monday's session ↗
Via Chartmill
Monday's session: most active stocks ↗
Via Chartmill
Which stocks are experiencing notable movement on Monday? ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
These stocks have an unusual volume in today's session ↗
Via Chartmill
Friday's session: most active stocks ↗
Via Chartmill
News headline image
Kartoon Studios (NYSE: TOON) Enters Next Growth Phase; Reports Q2 Revenue of $5.82M, EPS of $0.38 and $40.5M Cash Position – Plus More in Focus
Via AB Newswire
Topics Intellectual Property
These stocks have an unusual volume in today's session ↗
Via Chartmill
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
These stocks have an unusual volume in today's session ↗
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
Ukraine's Ministry Of Health Advances Entolimod Review Into Technical Assessment Phase
From Valion Bio, Inc.
Via ACCESS Newswire
These stocks are moving in today's pre-market session ↗
Via Chartmill

Frequently Asked Questions

Is Valion Bio, Inc. - Common stock publicly traded?
Yes, Valion Bio, Inc. - Common stock is publicly traded.
What exchange does Valion Bio, Inc. - Common stock trade on?
Valion Bio, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Valion Bio, Inc. - Common stock?
The ticker symbol for Valion Bio, Inc. - Common stock is VBIO on the Nasdaq Stock Market
What is the current price of Valion Bio, Inc. - Common stock?
The current price of Valion Bio, Inc. - Common stock is 2.000
When was Valion Bio, Inc. - Common stock last traded?
The last trade of Valion Bio, Inc. - Common stock was at 10/12/26 10:11 AM ET
What is the market capitalization of Valion Bio, Inc. - Common stock?
The market capitalization of Valion Bio, Inc. - Common stock is 224.58M
How many shares of Valion Bio, Inc. - Common stock are outstanding?
Valion Bio, Inc. - Common stock has 225M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.